HI SR42

Urges Hawaii's congressional delegation to monitor The Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, a federal case challenging FDA approval of mifepristone (the abortion pill).

Notes that mifepristone was FDA-approved on September 28, 2000, for medical termination of pregnancy through seven weeks of gestation, extended to ten weeks in 2016.

Expresses concern that a ruling in the Alliance case could effectively ban mifepristone nationwide and prevent healthcare providers from prescribing it even in states where abortion is legal.

Calls on Hawaii's congressional delegation to take action to limit the case from further restricting access to safe abortion and medication abortion options.

Requires certified copies of the resolution to be transmitted to members of Hawaii's congressional delegation.